Mitchell A. Rosenberg
Impact in
- Physiology top 5%
- Asthma and respiratory diseases
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
Papers in
-
- Drug-Induced Adverse Reactions 2
-
- Diabetes Treatment and Management 3
- Co-authors
- Elliot Israel (5 shared papers)Jeffrey M. Drazen (4 shared papers)Paul D. Rubin (3 shared papers)Andrew R. Fischer (3 shared papers)Craig M. Lilly (2 shared papers)JUDITH COHN (2 shared papers)Richard I. Sperling (1 shared paper)Graham W. Taylor (1 shared paper)
- Journals
- Experimental Cell Research (2 papers)JNCI Monographs (2 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Allergy and Clinical Immunology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Mitchell A. Rosenberg
16 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Physiology 621
- Immunology and Allergy 140
- Pharmacology 262
- Pulmonary and Respiratory Medicine 362
- Emergency Medical Services 55
Countries citing papers authored by Mitchell A. Rosenberg
This map shows the geographic impact of Mitchell A. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. Rosenberg more than expected).
Fields of papers citing papers by Mitchell A. Rosenberg
This network shows the impact of papers produced by Mitchell A. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. Rosenberg. The network helps show where Mitchell A. Rosenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell A. Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 325 | |
| 2 | 1993 | 322 | |
| 3 | 1994 | 151 | |
| 4 | 2006 | 132 | |
| 5 | 1997 | 110 | |
| 6 | 2006 | 94 | |
| 7 | 2007 | 60 | |
| 8 | 2007 | 53 | |
| 9 | 2006 | 45 | |
| 10 | 1992 | 41 | |
| 11 | 2007 | 38 | |
| 12 | 2007 | 33 | |
| 13 | 1997 | 17 | |
| 14 | 1969 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 2000 | 2 |
About Mitchell A. Rosenberg
Mitchell A. Rosenberg is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism, Physiology, Oncology and Occupational Therapy, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Asthma and respiratory diseases (3 papers), Drug-Induced Adverse Reactions (2 papers), Peptidase Inhibition and Analysis (2 papers), Studies on Chitinases and Chitosanases (1 paper), Microfluidic and Bio-sensing Technologies (1 paper), Analytical Methods in Pharmaceuticals (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Physiology (621 citations), Immunology and Allergy (140 citations), Pharmacology (262 citations), Pulmonary and Respiratory Medicine (362 citations) and Emergency Medical Services (55 citations). Mitchell A. Rosenberg has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Elliot Israel, Jeffrey M. Drazen, Paul D. Rubin, Andrew R. Fischer, Craig M. Lilly, JUDITH COHN, Richard I. Sperling, Graham W. Taylor, Jerry Shapiro and Amy Trentham‐Dietz. Their work appears in journals such as Experimental Cell Research, JNCI Monographs, The Journal of Clinical Pharmacology, Journal of Allergy and Clinical Immunology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.